MIKE DAVIS: Foreign weight-loss drugmaker seeks fat profits by gobbling up American upstart
Novo Nordisk attempts to acquire weight-loss drug company Metsera during government shutdown, potentially avoiding FTC antitrust review and regulatory scrutiny.
